Edition:
United Kingdom

Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

50.70CHF
2:15pm GMT
Change (% chg)

CHF-1.50 (-2.87%)
Prev Close
CHF52.20
Open
CHF52.40
Day's High
CHF52.40
Day's Low
CHF49.24
Volume
55,703
Avg. Vol
59,331
52-wk High
CHF73.95
52-wk Low
CHF38.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 46.62 -2.074
FY 2017 Dec '17 49.51 0.111
Jun '17 41.17 -1.899
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-19 1 46.00 46.00 46.00 --
Year Ending Dec-19 6 127.47 137.30 118.00 98.05
Earnings (per share)
Quarter Ending Dec-19 1 -1.56 -1.56 -1.56 --
Year Ending Dec-19 5 -2.66 -1.20 -3.80 -0.55
LT Growth Rate (%) 1 -19.20 -19.20 -19.20 --
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta 1.31 1.08 0.90
Price to Sales (TTM) 12.39 49.51 6.29
Price to Book (MRQ) -- 10.14 5.26
Price to Tangible Book (MRQ) -- 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions -- 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg 1.21 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 38.49 205.92 12.75
Sales (TTM) vs TTM 1 Yr. Ago 35.14 48.79 5.84
Sales - 5 Yr. Growth Rate -0.50 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 31.18 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago 28.13 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate -34.31 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.78 2.24 2.25
Current Ratio (MRQ) 2.98 3.50 3.08
LT Debt to Equity (MRQ) -- 18.65 11.38
Total Debt to Equity (MRQ) -- 31.33 16.12
Interest Coverage (TTM) -17.38 -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 92.31 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -45.22 -- --
EBITD - 5 Yr. Avg -84.28 -110.40 12.87
Operating Margin (TTM) -48.03 -184.63 6.20
Operating Margin - 5 Yr. Avg. -89.66 -126.89 8.31
Pre-Tax Margin (TTM) -56.97 -175.33 7.16
Pre-Tax Margin - 5 Yr. Avg. -92.75 -132.68 8.61
Net Profit Margin (TTM) -57.44 -182.03 3.30
Net Profit Margin - 5 Yr. Avg. -93.21 -137.07 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 318,667 7,654,601 842,398,385
Net Income/Employee (TTM) -183,042 562,114 99,842,801
Receivable Turnover (TTM) 27.34 6.23 5.71
Inventory Turnover (TTM) 0.45 1.89 3.47
Asset Turnover (TTM) 0.24 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -13.74 6.39 11.06
Return on Assets - 5 Yr. Avg. -14.90 5.47 12.20
Return on Investment (TTM) -17.70 8.92 14.45
Return on Investment - 5 Yr. Avg. -18.35 6.78 15.87
Return on Equity (TTM) -- 10.08 15.96
Return on Equity - 5 Yr. Avg. -78.01 8.32 17.00
  1 Year 3 Year 5 Year
Sales % 25.91 16.67 -0.50
EPS (TTM) % 16.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Basilea Pharmaceutica AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.17 -4.81 99 99
13 Week -1.24 -5.17 99 95
26 Week -5.55 -11.79 99 98
52 Week 5.61 -6.73 99 72
YTD 9.37 -2.83 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 32.01%
# of Holders: 63
Total Shares Held: 3,801,978
3 Mo. Net Change: 27,618
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 14
# Reduced Positions: 7
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.